Table 2. Survival of our patients.
Variables | Survival | P | ||
---|---|---|---|---|
Median (months) | Minimum | Maximum | ||
Overall median (n=101) (Figure 1) | 8 | 0.5 | 78 | |
Gender | ns | |||
Overall females (n=35) | 7 | 1 | 78 | |
Overall males (n=66) | 8 | 0.5 | 34 | |
Diagnosis | ns | |||
Overall ADC (n=71) | 8 | 0.5 | 78 | |
Overall squamous cell carcinoma (n=13) | 5 | 0.5 | 16 | |
Overall small-cell carcinoma (n=12) | 4.5 | 1 | 17 | |
PE | ||||
Overall at follow-up (n=25) | 11 | 3 | 78 | 0.009 (Figure 2) |
Overall at diagnosis (n=76) | 6 | 0.5 | 35 | |
Overall from PE appearance (n=101) | 5 | 0.5 | 35 | |
Overall from PE appearance at diagnosis (n=76) | 6 | 0.5 | 35 | <0.0001 (Figure 3) |
Overall from PE appearance during follow-up (n=25) | 1 | 0.5 | 13 |
ADC, adenocarcinoma; PE, pleural effusion; ns, no significance.